1599440-13-7 Usage
Description
N-[6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]glycylglycyl-L-phenylalanyl-N-[(2-[(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino-2-oxoethoxy)methyl]glycinamide is a complex organic compound with a unique molecular structure. It is characterized by its intricate arrangement of atoms and functional groups, which may have potential applications in various fields due to its specific properties.
Uses
1. Used in Pharmaceutical Industry:
N-[6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]glycylglycyl-L-phenylalanyl-N-[(2-[(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino-2-oxoethoxy)methyl]glycinamide is used as a potential therapeutic agent for targeting specific biological pathways. Its complex structure may allow for high specificity and affinity towards certain molecular targets, making it a candidate for the development of new drugs.
2. Used in Research and Development:
In the field of research, this compound can be utilized for studying various biological processes and interactions. Its unique structure may provide insights into the mechanisms of action of different proteins and enzymes, contributing to the advancement of scientific knowledge.
3. Used in Drug Synthesis:
N-[6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]glycylglycyl-L-phenylalanyl-N-[(2-[(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino-2-oxoethoxy)methyl]glycinamide can be employed as a building block or a key intermediate in the synthesis of more complex molecules with potential pharmaceutical applications.
4. Used in Drug Delivery Systems:
N-[6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]glycylglycyl-L-phenylalanyl-N-[(2-[(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino-2-oxoethoxy)methyl]glycinamide may also be used in the development of drug delivery systems, where its unique properties can be exploited to improve the bioavailability, targeting, and release of therapeutic agents.
Please note that the specific applications and uses mentioned above are hypothetical and based on the assumption that the compound has certain properties due to its complex structure. Actual applications may vary and would require further research and development to confirm.
Check Digit Verification of cas no
The CAS Registry Mumber 1599440-13-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,9,9,4,4 and 0 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1599440-13:
(9*1)+(8*5)+(7*9)+(6*9)+(5*4)+(4*4)+(3*0)+(2*1)+(1*3)=207
207 % 10 = 7
So 1599440-13-7 is a valid CAS Registry Number.
1599440-13-7Relevant articles and documents
Antibody-based drug conjugate with two different drugs
-
Paragraph 0098-0099; 0118-0120, (2018/12/13)
The invention discloses an antibody-based drug conjugate with two different drugs. According to the invention, a drug is connected to cysteine residue of an antibody in a fixed-point coupling mode, and another cytotoxic drug with different action mechanism is connected to the cysteine residue of the antibody in a non-fixed point coupling mode.
